|
Press Releases |
|
|
|
Thursday, August 20, 2020 |
|
Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for Infected Elderly and Frontline Workers |
Triple therapy specialist Professor Thomas Borody, famous for curing peptic ulcers using a triple antibiotic therapy saving millions of lives, has released the COVID-19 treatment protocol to Australian GPs, who can legally prescribe it to their COVID-19 positive patients. more info >> |
|
Friday, May 19, 2017 |
|
Microbiome leader Professor Borody calls for a National Australian FMT Bank to fight Drug Resistant Diseases |
Faecal Microbiota Transplantation (FMT) leader Professor Thomas Borody (MD, PhD) has called for a national faecal bank to fight drug resistant and epidemic diseases in hospitals and clinics across the country. more info >> |
|
Tuesday, May 16, 2017 |
|
微生物组领导者Borody教授与其他研究人员一起参加中国微生物组移植会议 |
在中国南京举行的中国微生物组移植会议上,全球粪便微生物群移植(FMT) 领导者Thomas Borody (MD, PhD) 教授发表了有关艰难梭菌疾病的主旨演讲,介绍中国粪便移植将治疗IBD、关节炎、帕金森氏病甚至MS等疾病的未来(2017年4月12-14日)。 more info >> |
|
微生物組領導者Borody教授與其他研究人員一起參加中國微生物組移植會議 |
在中國南京舉行的中國微生物組移植會議上,全球糞便微生物群移植(FMT) 領導者Thomas Borody (MD, PhD) 教授發表了有關艱難梭菌疾病的主旨演講,介紹中國糞便移植將治療IBD、關節炎、帕金森氏病甚至MS等疾病的未來(2017年4月12-14日) more info >> |
|
Microbiome leader Prof. Borody at China FMT Conference calls for Investment in Faecal Transplant Clinical Trials to Fight Serious Diseases |
A future where faecal transplants in China will cure conditions like autism, IBD, arthritis, Parkinson's disease and even MS was presented by global Faecal Microbiota Transplantation (FMT) leader Professor Thomas Borody (MD, PhD) at the opening of the China Microbiota Transplantation Conference in Nanjing. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
王朝酒业公布2023年全年业绩
Mar 28, 2024 17:45 HKT/SGT
|
|
|
王朝酒業公佈2023年全年業績
Mar 28, 2024 17:42 HKT/SGT
|
|
|
Dynasty Fine Wines Announces 2023 Annual Results
Mar 28, 2024 17:35 HKT/SGT
|
|
|
东软教育:内生高质量发展 数字化赋能打开长远增长空间
Mar 28, 2024 16:45 HKT/SGT
|
|
|
東軟教育:內生高質量發展 數字化賦能打開長遠增長空間
Mar 28, 2024 16:42 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Receives Order from the University of Tokyo for "MiPoLin" Power Prediction and Lines Selection System
Mar 28, 2024 16:45 JST
|
|
|
浙江沪杭甬:业绩稳健向好 积极回馈股东 分红总额增长17.7%
Mar 28, 2024 15:43 HKT/SGT
|
|
|
浙江滬杭甬:業績穩健向好 積極回饋股東 分紅總額增長17.7%
Mar 28, 2024 15:37 HKT/SGT
|
|
|
2023年收入、利潤實現「雙增長」 復星下一步:「深挖礦」,穩盈利
Mar 28, 2024 15:31 HKT/SGT
|
|
|
Fosun's Next Step: "Deep Mining" for Stable Profits
Mar 28, 2024 15:26 HKT/SGT
|
|
|
国际债券持有人特别团体(“持有人特别团体”)指示受托人 向香港上市公司希教国际控股(1765.HK)送达清盘呈请书
Mar 28, 2024 15:21 HKT/SGT
|
|
|
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study
Mar 28, 2024 14:42 HKT/SGT
|
|
|
IGG集團全年扭虧為盈 下半年盈利逾4.3億港元
Mar 28, 2024 14:33 HKT/SGT
|
|
|
Turning Loss into Profit in 2023: IGG Achieved over HK$430 million in 2H23
Mar 28, 2024 14:25 HKT/SGT
|
|
|
朝雲集團2023年營收純利雙增,派息分紅比例持續走高
Mar 28, 2024 14:10 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|